The Hanmi’s Esomezol has tasted bitterness in the U.S. market, but learned something
Amneal, taking charge of the sale right of the Hanmi Pharm’s reflux esophagitis treatment, Esomezol(esomeprazole strontium), has practically stopped its distribution in a year and a half.
Recently, Amneal made an announcement in its webpage that it will make a suspension of the Esomezol distribu...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
